Literature DB >> 29804834

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome.

Brian T Weinert1, Takeo Narita1, Shankha Satpathy1, Balaji Srinivasan1, Bogi K Hansen1, Christian Schölz2, William B Hamilton3, Beth E Zucconi4, Wesley W Wang5, Wenshe R Liu5, Joshua M Brickman3, Edward A Kesicki6, Albert Lai7, Kenneth D Bromberg7, Philip A Cole4, Chunaram Choudhary8.   

Abstract

The acetyltransferases CBP and p300 are multifunctional transcriptional co-activators. Here, we combined quantitative proteomics with CBP/p300-specific catalytic inhibitors, bromodomain inhibitor, and gene knockout to reveal a comprehensive map of regulated acetylation sites and their dynamic turnover rates. CBP/p300 acetylates thousands of sites, including signature histone sites and a multitude of sites on signaling effectors and enhancer-associated transcriptional regulators. Time-resolved acetylome analyses identified a subset of CBP/p300-regulated sites with very rapid (<30 min) acetylation turnover, revealing a dynamic balance between acetylation and deacetylation. Quantification of acetylation, mRNA, and protein abundance after CBP/p300 inhibition reveals a kinetically competent network of gene expression that strictly depends on CBP/p300-catalyzed rapid acetylation. Collectively, our in-depth acetylome analyses reveal systems attributes of CBP/p300 targets, and the resource dataset provides a framework for investigating CBP/p300 functions and for understanding the impact of small-molecule inhibitors targeting its catalytic and bromodomain activities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A-485; CBP; acetylation; acetylation kinetics; bromodomain; enhancer; gene transcription; mass spectrometry; p300; proteomics

Mesh:

Substances:

Year:  2018        PMID: 29804834      PMCID: PMC6078418          DOI: 10.1016/j.cell.2018.04.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  50 in total

1.  Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity.

Authors:  P R Thompson; H Kurooka; Y Nakatani; P A Cole
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

2.  Avoiding abundance bias in the functional annotation of post-translationally modified proteins.

Authors:  Christian Schölz; David Lyon; Jan C Refsgaard; Lars Juhl Jensen; Chunaram Choudhary; Brian T Weinert
Journal:  Nat Methods       Date:  2015-11       Impact factor: 28.547

Review 3.  Acetylation of non-histone proteins modulates cellular signalling at multiple levels.

Authors:  Stephanie Spange; Tobias Wagner; Thorsten Heinzel; Oliver H Krämer
Journal:  Int J Biochem Cell Biol       Date:  2008-09-02       Impact factor: 5.085

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

Review 5.  50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.

Authors:  Eric Verdin; Melanie Ott
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-30       Impact factor: 94.444

6.  CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation.

Authors:  Lawryn H Kasper; Stephanie Lerach; Jianmin Wang; Song Wu; Trushar Jeevan; Paul K Brindle
Journal:  EMBO J       Date:  2010-09-21       Impact factor: 11.598

7.  Synthetic transcription elongation factors license transcription across repressive chromatin.

Authors:  Graham S Erwin; Matthew P Grieshop; Asfa Ali; Jun Qi; Matthew Lawlor; Deepak Kumar; Istaq Ahmad; Anna McNally; Natalia Teider; Katie Worringer; Rajeev Sivasankaran; Deeba N Syed; Asuka Eguchi; Md Ashraf; Justin Jeffery; Mousheng Xu; Paul M C Park; Hasan Mukhtar; Achal K Srivastava; Mohammed Faruq; James E Bradner; Aseem Z Ansari
Journal:  Science       Date:  2017-11-30       Impact factor: 47.728

8.  Mfuzz: a software package for soft clustering of microarray data.

Authors:  Lokesh Kumar; Matthias E Futschik
Journal:  Bioinformation       Date:  2007-05-20

9.  Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

Authors:  Sarah Picaud; Oleg Fedorov; Angeliki Thanasopoulou; Katharina Leonards; Katherine Jones; Julia Meier; Heidi Olzscha; Octovia Monteiro; Sarah Martin; Martin Philpott; Anthony Tumber; Panagis Filippakopoulos; Clarence Yapp; Christopher Wells; Ka Hing Che; Andrew Bannister; Samuel Robson; Umesh Kumar; Nigel Parr; Kevin Lee; Dave Lugo; Philip Jeffrey; Simon Taylor; Matteo L Vecellio; Chas Bountra; Paul E Brennan; Alison O'Mahony; Sharlene Velichko; Susanne Müller; Duncan Hay; Danette L Daniels; Marjeta Urh; Nicholas B La Thangue; Tony Kouzarides; Rab Prinjha; Jürg Schwaller; Stefan Knapp
Journal:  Cancer Res       Date:  2015-11-09       Impact factor: 12.701

10.  Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.

Authors:  Michael R Michaelides; Arthur Kluge; Michael Patane; John H Van Drie; Ce Wang; T Matthew Hansen; Roberto M Risi; Robert Mantei; Carmen Hertel; Kannan Karukurichi; Alexandre Nesterov; David McElligott; Peter de Vries; J William Langston; Philip A Cole; Ronen Marmorstein; Hong Liu; Loren Lasko; Kenneth D Bromberg; Albert Lai; Edward A Kesicki
Journal:  ACS Med Chem Lett       Date:  2017-12-13       Impact factor: 4.345

View more
  99 in total

1.  Single-Molecule Nanoscopy Elucidates RNA Polymerase II Transcription at Single Genes in Live Cells.

Authors:  Jieru Li; Ankun Dong; Kamola Saydaminova; Hill Chang; Guanshi Wang; Hiroshi Ochiai; Takashi Yamamoto; Alexandros Pertsinidis
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

2.  Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.

Authors:  Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-19       Impact factor: 4.310

3.  Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP.

Authors:  Beth E Zucconi; Jessica L Makofske; David J Meyers; Yousang Hwang; Mingxuan Wu; Mitzi I Kuroda; Philip A Cole
Journal:  Biochemistry       Date:  2019-04-11       Impact factor: 3.162

4.  The Acetylation of Lysine-376 of G3BP1 Regulates RNA Binding and Stress Granule Dynamics.

Authors:  Jozsef Gal; Jing Chen; Duck-Young Na; Laura Tichacek; Kelly R Barnett; Haining Zhu
Journal:  Mol Cell Biol       Date:  2019-10-28       Impact factor: 4.272

Review 5.  Pharmacological Modulation of Transcriptional Coregulators in Cancer.

Authors:  Timothy R Bishop; Yuxiang Zhang; Michael A Erb
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

6.  Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility.

Authors:  Cyril S Anyetei-Anum; Rochelle M Evans; Amanda M Back; Vincent R Roggero; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2019-07-15       Impact factor: 4.102

7.  Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins.

Authors:  Ibraheem Ali; Diego Garrido Ruiz; Zuyao Ni; Jeffrey R Johnson; Heng Zhang; Pao-Chen Li; Mir M Khalid; Ryan J Conrad; Xinghua Guo; Jinrong Min; Jack Greenblatt; Matthew Jacobson; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2019-05-01       Impact factor: 17.970

8.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

Authors:  Karsten Krug; Eric J Jaehnig; Shankha Satpathy; Lili Blumenberg; Alla Karpova; Meenakshi Anurag; George Miles; Philipp Mertins; Yifat Geffen; Lauren C Tang; David I Heiman; Song Cao; Yosef E Maruvka; Jonathan T Lei; Chen Huang; Ramani B Kothadia; Antonio Colaprico; Chet Birger; Jarey Wang; Yongchao Dou; Bo Wen; Zhiao Shi; Yuxing Liao; Maciej Wiznerowicz; Matthew A Wyczalkowski; Xi Steven Chen; Jacob J Kennedy; Amanda G Paulovich; Mathangi Thiagarajan; Christopher R Kinsinger; Tara Hiltke; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Thomas F Westbrook; Li Ding; Gad Getz; Karl R Clauser; David Fenyö; Kelly V Ruggles; Bing Zhang; D R Mani; Steven A Carr; Matthew J Ellis; Michael A Gillette
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

9.  Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.

Authors:  Alexandra Arenas; Jing Chen; Lisha Kuang; Kelly R Barnett; Edward J Kasarskis; Jozsef Gal; Haining Zhu
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

Review 10.  The Chemical Biology of Reversible Lysine Post-translational Modifications.

Authors:  Zhipeng A Wang; Philip A Cole
Journal:  Cell Chem Biol       Date:  2020-07-21       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.